Foretinib Completed Phase 1 Trials for Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00920192Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer